Katrina Woodford, Vanessa Panettieri, Trieumy Tran Le, Sashendra Senthi
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database Survey
10.1097/jto.0b013e3181c5920c · 2010
Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd ed.)
10.1378/chest.07-1379 · 2007
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer
10.1200/jco.2009.26.2543 · 2010
Increasing rates of no treatment in advanced-stage non-small cell lung cancer patients: a propensity-matched analysis
10.1016/j.jtho.2016.11.2221 · 2017
Treatment of the elderly when cure is the goal: the influence of Age on Treatment Selection and Efficacy for Stage III Non-small Cell Lung Cancer
10.1097/jto.0b013e31820b8b9b · 2011
Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans
10.1200/jco.2011.39.5269 · 2012
Management of clinical stage IIIA primary lung cancers in the national cancer database
10.1016/j.athoracsur.2014.04.067 · 2014
Variability in the treatment of elderly patients with stage IIIA (N2) Non-Small-Cell Lung Cancer
10.1097/jto.0b013e31828916aa · 2013
Lung cancer in the elderly
10.1200/jco.2006.10.3085 · 2007
SPACE – a randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC
10.1016/j.radonc.2016.08.015 · 2016
Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I Non-Small-Cell Lung Cancer
10.1016/j.ijrobp.2007.10.053 · 2008
Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands
10.1093/annonc/mds081 · 2012
Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume
10.1016/j.radonc.2007.11.022 · 2008
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus
10.1016/j.ijrobp.2010.07.1977 · 2011
10.1016/s1470-2045(14)71207-0
10.1016/s1470-2045(14)71207-0 · 2015
An overview of hypofractionation and introduction to this issue of seminars in radiation oncology
10.1016/j.semradonc.2008.04.001 · 2008
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial
10.1186/1471-2407-12-305 · 2012
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer
10.1200/jco.2006.07.5937 · 2006
Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study
10.1016/j.ejca.2011.06.023 · 2011
Older patients with inoperable non-small cell lung cancer
10.1007/s00066-014-0710-5 · 2014
Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review
10.1016/s0360-3016(99)00130-3 · 1999
Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoperable non-small cell lung cancer
10.1186/1748-717x-7-33 · 2012
Precision hypofractionated radiation therapy in poor performing patients with Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial
10.1016/j.ijrobp.2015.05.004 · 2015
Optimal dose and fraction number in SBRT of lung tumours: a radiobiological analysis
10.1016/j.ejmp.2016.12.012 · 2017
No additional external references are available.
